CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...